Zalcitabine
Term · Oncology and biomedicine · MLC-T-ONC-017646
A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zalcitabine preferentially inhibits the gamma form of DNA polymerase present in tumor cell mitochondria, resulting in the inhibition of tumor cell mitochondrial DNA replication and tumor cell death.
| Identifier | MLC-T-ONC-017646 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ddC |
| Synonyms | dideoxycytidine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017646",
"term": "Zalcitabine",
"field": "Oncology and biomedicine",
"definition": "A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zalcitabine preferentially inhibits the gamma form of DNA polymerase present in tumor cell mitochondria, resulting in the inhibition of tumor cell mitochondrial DNA replication and tumor cell death.",
"abbreviation": "ddC",
"synonyms": [
"dideoxycytidine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/zalcitabine/"
}
Record 17,588 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.